Annexon, Inc. (ANNX) vs Fulgent Genetics, Inc. (FLGT)

A side-by-side comparison of Annexon, Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ANNX vs FLGT

growth of $100 · dividends reinvested · last 6y
ANNX -76.4% (-21.4%/yr)FLGT +15.1% (+2.4%/yr)FLGT compounded faster over this window
0200400600800Start $100202120222023202420252026$24$115
ANNX FLGT

ANNX vs FLGT: by the numbers

  • •ANNX is the larger company ($688M vs $638M market cap).
  • •Both run net losses; ANNX's is the smaller (0.00% vs -26.05% net margin).

Metrics side by side

Valuation

MetricANNXFLGT
P/S ratioN/A1.97
P/B ratio3.700.64

Profitability

MetricANNXFLGT
Gross margin0.00%35.58%
Operating margin0.00%-28.23%
Net margin0.00%-26.05%
ROE-108.93%-8.42%
ROIC-101.43%-11.80%

Growth (annualized)

MetricANNXFLGT
Revenue CAGR (5Y)N/A-18.66%
Total return CAGR (5Y)-26.29%-22.38%

Frequently asked

How have ANNX and FLGT total returns compared?
Over the past 5 years, ANNX delivered -26.29% and FLGT delivered -22.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.